MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.

Published on IRCCS materno infantile Burlo Garofolo (https://www.burlo.trieste.it)

MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. [1]

Titolo	MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.
Publication Type	Journal Article
Authors	Secchiero, P [2], Melloni, E [3], Voltan, R [4], Norcio, A [5], Celeghini, C [6], Zauli, G [7]
PubMed ID	22313359 [8]

Source URL: https://www.burlo.trieste.it/ricerca/pubblicazioni/mcl1-down-regulation-plays-critical-role-mediating-higher-anti-leukaemic-activity-multi-kinase-inhibitor#comment-0

Collegamenti
[1] https://www.burlo.trieste.it/ricerca/pubblicazioni/mcl1-down-regulation-plays-critical-role-mediating-higher-anti-leukaemic-activity-multi-kinase-inhibitor
[2] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=98
[3] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=269
[4] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=224
[5] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=1879
[6] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=225
[7] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=104
[8] http://www.ncbi.nlm.nih.gov/pubmed/22313359?dopt=Abstract